Cargando…

The burden of 14 hr-HPV genotypes in women attending routine cervical cancer screening in 20 states of Mexico: a cross-sectional study

In Mexico, HPV vaccines available immunize against genotypes 16/18 and 16/18/6/11; however, there is limited surveillance about carcinogenic subtypes in different states of the country that allow evaluating the effectiveness of vaccination and cervical cancer screening programs. Here, we report the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campos-Romero, Abraham, Anderson, Karen S., Longatto-Filho, Adhemar, Luna-Ruiz Esparza, Marco A., Morán-Portela, David J., Castro-Menéndez, Javier A., Moreno-Camacho, José L., Calva-Espinosa, Diana Y., Acosta-Alfaro, Manuel A., Meynard-Mejía, Freddy A., Muñoz-Gaitán, Marlene, Alcántar-Fernández, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626130/ https://www.ncbi.nlm.nih.gov/pubmed/31300693 http://dx.doi.org/10.1038/s41598-019-46543-8

Ejemplares similares

Human papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspective
por: Lorenzi, Adriana T., et al.
Publicado: (2015)

Human papillomavirus (HPV) 16 infection is not detected in rectal carcinoma
por: Martins, Sandra F., et al.
Publicado: (2020)

Seroconversion dynamic and SARS-CoV-2 seropositivity in unvaccinated population during the first and second outbreaks in Mexico
por: Fernández-Rojas, Miguel A., et al.
Publicado: (2022)

Longitudinal analysis on the ecological dynamics of the cervicovaginal microbiome in hrHPV infection
por: Molina, Mariano A., et al.
Publicado: (2023)

Cytokine Release in HR-HPV(+) Women without and with Cervical Dysplasia (CIN II and III) or Carcinoma, Compared with HR-HPV([Formula: see text]) Controls
por: Bais, Aagje G., et al.
Publicado: (2007)

The integration of HR-HPV increases the expression of cyclins A and E in cytologies with and without low-grade lesions
por: Zubillaga-Guerrero, MI, et al.
Publicado: (2013)

Health economic evaluation of an mRNA high-risk human papillomavirus (HR-HPV) assay versus a DNA HR-HPV assay for the proposed French cervical screening programme
por: Dombrowski, Caroline A., et al.
Publicado: (2022)

Comparing the Cervista HPV HR Test and Hybrid Capture 2 Assay in a Dutch Screening Population: Improved Specificity of the Cervista HPV HR Test by Changing the Cut-Off
por: Boers, Aniek, et al.
Publicado: (2014)

hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy
por: Carozzi, F, et al.
Publicado: (2013)

Use of extended HR-HPV Genotyping in improving the Triage Strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology Results
por: Xue, Huifeng, et al.
Publicado: (2021)

Assessing the Cervicovaginal Microbiota in the Context of hrHPV Infections: Temporal Dynamics and Therapeutic Strategies
por: Molina, Mariano A., et al.
Publicado: (2022)

Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix
por: Pinheiro, Céline, et al.
Publicado: (2014)

ART is key to clearing oncogenic HPV genotypes (HR-HPV) in anal mucosa of HIV-positive MSM
por: Hidalgo-Tenorio, Carmen, et al.
Publicado: (2019)

hrHPV E5 oncoprotein: immune evasion and related immunotherapies
por: de Freitas, Antonio Carlos, et al.
Publicado: (2017)

Determination and evaluation of HR-HPV genotype in different communities of Bihar, India
por: Parwez, Akhtar, et al.
Publicado: (2022)

Impact of HR-HPV infection on oncological outcomes in early cervical cancer
por: Su, Xiaoqiang, et al.
Publicado: (2023)

Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda
por: Sinayobye, Jean d’Amour, et al.
Publicado: (2014)

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012)

Epidemiology of COVID-19 in Mexico: Symptomatic profiles and presymptomatic people
por: Fernández-Rojas, Miguel A., et al.
Publicado: (2021)

Awareness and knowledge of HPV, cervical cancer, and vaccines in young women after first delivery in São Paulo, Brazil - a cross-sectional study
por: Rama, Cristina H, et al.
Publicado: (2010)

Viral load and high prevalence of HR-HPV52 and 58 types in black women from rural communities
por: Volpini, Lays Paula Bondi, et al.
Publicado: (2021)

The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL
por: Possati-Resende, Júlio C., et al.
Publicado: (2015)

Implementation of HPV Tests in Latin America: What We Learned; What Should We Have Learned, and What Can We Do Better?
por: Godoy, Luani Rezende, et al.
Publicado: (2022)

LINE-1 and Alu Methylation in hrHPV-Associated Precancerous Cervical Samples
por: Chaiwongkot, Arkom, et al.
Publicado: (2022)

In-depth insights into cervicovaginal microbial communities and hrHPV infections using high-resolution microbiome profiling
por: Molina, Mariano A., et al.
Publicado: (2022)

Preferences and Experiences Regarding the Use of the Self-Sampling Device in hrHPV Screening for Cervical Cancer
por: Dieleman, Marjolein, et al.
Publicado: (2021)

Distinct Patterns of Myeloid Cell Infiltration in Patients With hrHPV-Positive and hrHPV-Negative Penile Squamous Cell Carcinoma: The Importance of Assessing Myeloid Cell Densities Within the Spatial Context of the Tumor
por: Rafael, Tynisha S., et al.
Publicado: (2021)

HR Organigramme
por: Favre, A
Publicado: (2001)

Organigramme HR
por: Favre, A
Publicado: (2011)

DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women
por: Boers, A, et al.
Publicado: (2014)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022)

Molecular characterization of high-risk human papillomavirus (HR-HPV) in women in Lomé, Togo
por: Kuassi-Kpede, Akouélé P., et al.
Publicado: (2021)

Papillomavirus from the Bench to the Clinics
por: Longatto Filho, Adhemar, et al.
Publicado: (2012)

Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options
por: Rodrigues, Daniela, et al.
Publicado: (2016)

hrHPV prevalence and type distribution in rural Zimbabwe: A community-based self-collection study using near-point-of-care GeneXpert HPV testing
por: Fitzpatrick, Megan B., et al.
Publicado: (2019)

HPV16 Oncoproteins Induce MMPs/RECK-TIMP-2 Imbalance in Primary Keratinocytes: Possible Implications in Cervical Carcinogenesis
por: Cardeal, Laura Beatriz da Silva, et al.
Publicado: (2012)

Evaluation of 3D-CPA, HR-HPV, and TCT joint detection on cervical disease screening
por: Liang, Hui, et al.
Publicado: (2016)

Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays
por: Dippmann, Carolin, et al.
Publicado: (2020)

Clinical and Analytical Evaluation of the Alinity m HR HPV Assay within the VALGENT-3 Framework
por: Dhillon, Sharonjit K., et al.
Publicado: (2021)

High-risk Human Papillomavirus (hrHPV) Prevalence and Genotype Distribution among Turkish Women
por: Gecer, Melin
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4b55etcagr86gqbr133g78c84t